TJBH Tengjun Biotechnology Corp

Price (delayed)

$3.00

Market cap

$137.35M

P/E Ratio

N/A

Dividend/share

N/A

EPS

$0

Enterprise value

$137.65M

Sector: Communication Services
Industry: Broadcasting

Highlights

Tengjun Biotechnology's net income has increased by 12% YoY
Tengjun Biotechnology's quick ratio has shrunk by 50% QoQ
TJBH's debt is up by 7% since the previous quarter and by 3.7% year-on-year

Key stats

What are the main financial stats of TJBH
Market
Shares outstanding
45.78M
Market cap
$137.35M
Enterprise value
$137.65M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
N/A
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Earnings
Revenue
$0
EBIT
-$32,252
EBITDA
-$32,252
Free cash flow
-$33,764
Per share
EPS
$0
Free cash flow per share
$0
Book value per share
-$0.01
Revenue per share
$0
TBVPS
$0
Balance sheet
Total assets
$19,187
Total liabilities
$313,019
Debt
$301,433
Equity
-$293,832
Working capital
-$293,832
Liquidity
Debt to equity
-1.03
Current ratio
0.06
Quick ratio
0.01
Net debt/EBITDA
-9.22
Margins
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Efficiency
Return on assets
-453.6%
Return on equity
N/A
Return on invested capital
N/A
Return on capital employed
N/A
Return on sales
N/A
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

TJBH stock price

How has the Tengjun Biotechnology stock price performed over time
Intraday
0%
1 week
0%
1 month
-94.55%
1 year
-94.55%
YTD
-94.55%
QTD
-94.55%

Financial performance

How have Tengjun Biotechnology's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$32,252
Net income
-$53,882
Gross margin
N/A
Net margin
N/A
The operating income rose by 20% YoY
Tengjun Biotechnology's net income has increased by 12% YoY

Growth

What is Tengjun Biotechnology's growth rate over time

Valuation

What is Tengjun Biotechnology stock price valuation
P/E
N/A
P/B
N/A
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
TJBH's equity is down by 4% since the previous quarter

Efficiency

How efficient is Tengjun Biotechnology business performance
The company's return on assets rose by 34% YoY and by 13% QoQ

Dividends

What is TJBH's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for TJBH.

Financial health

How did Tengjun Biotechnology financials performed over time
The total assets is 94% lower than the total liabilities
Tengjun Biotechnology's current ratio has surged by 100% QoQ and by 50% YoY
The total assets has soared by 87% QoQ and by 46% YoY
TJBH's debt is up by 7% since the previous quarter and by 3.7% year-on-year
TJBH's equity is down by 4% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.